February 13, 2020 / 10:02 PM / 4 days ago

BRIEF-Sol-Gel Announces Positive Topline Results From Open-Label, Long-Term Safety Study Of Epsolay® For Treatment Up To 52 Weeks

Feb 13 (Reuters) - Sol Gel Technologies Ltd:

* SOL-GEL ANNOUNCES POSITIVE TOPLINE RESULTS FROM OPEN-LABEL, LONG-TERM SAFETY STUDY OF EPSOLAY® FOR TREATMENT UP TO 52 WEEKS

* SOL GEL TECHNOLOGIES - NON-CUTANEOUS ADVERSE EVENTS WERE SIMILAR IN FREQUENCY AND TYPE TO THOSE OBSERVED IN PRECEDING PHASE 3 TRIALS

* SOL GEL TECHNOLOGIES LTD - NO SERIOUS DRUG-RELATED ADVERSE EVENTS WERE REPORTED IN TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below